Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Characterization of Treatment Received by NLST Participants

Principal Investigator
Name
Erik Henne
Institution
Uptake Medical
Position Title
Vice President, Lung Cancer Program
Email
About this CDAS Project
Study
NLST (Learn more about this study)
Project ID
NLST-99
Initial CDAS Request Approval
Dec 5, 2014
Title
Characterization of Treatment Received by NLST Participants
Summary
Lung cancer treatment is dependent on many characteristics including the type of lung cancer, nodule characteristics (e.g. size and location), and stage at diagnosis. These characteristics inform whether a patient is suitable for surgical intervention. Surgery is often the standard treatment for local disease. However, many patients are considered inoperable due to comorbidities, who need other treatment options. The intent of this project is to 1) characterize inoperable patients to understand the reasons for inoperability and 2) characterize the treatment approaches used for NLST participants.
Aims

1. Characterize inoperable NLST patients to understand the reasons for inoperability
2. Characterize treatment received by inoperable and operable NLST participants with respect to nodule size, stage at diagnosis, and lung cancer progression